	应收帐款人		日
AbbVie	USD 12.59B	180M	2025-12
Amgen	USD 9.14B	432M	2026-03
Anika Therapeutics	USD 29.33M	661K	2025-12
Arrowhead Research	USD 218.87M	212.05M	2025-12
AstraZeneca	USD 17.88B	1.17B	2026-03
BioCryst Pharmaceuticals	USD 106.82M	15.49M	2025-12
Biogen	USD 1.79B	76.6M	2026-03
Bristol-Myers Squibb	USD 14.36B	164M	2026-03
Enanta Pharmaceuticals	USD 40.16M	1.52M	2024-12
Gilead Sciences	USD 4.91B	182M	2025-12
GlaxoSmithKline	GBP 7.94B	178M	2026-03
Halozyme Therapeutics	USD 441.27M	95.24M	2025-12
Heron Therapeutics	USD 89.59M	8.54M	2025-12
Immunic	USD 333K	156K	2025-12
Incyte	USD 1.05B	27.09M	2026-03
Insmed	USD 140.86M	75.6M	2025-12
Ionis Pharmaceuticals	USD 74M	8M	2026-03
J&J	USD 21.33B	3.72B	2025-12
Karyopharm Therapeutics	USD 26.18M	5.6M	2025-12
Ligand Pharmaceuticals	USD 58.1M	15.98M	2025-09
Merck	USD 11.78B	345M	2025-12
Neurocrine Biosciences	USD 686.8M	41.2M	2025-12
Novartis	USD 9.6B	2.69B	2026-03
Novavax	USD 106.45M	72.27M	2025-12
Pfizer	USD 15.84B	2.27B	2025-12
PTC Therapeutics	USD 181.62M	21.45M	2025-12
Roche Holding	CHF 11.9B	460M	2025-12
Sarepta Therapeutics	USD 398.23M	2.49M	2025-12
Vertex Pharmaceuticals	USD 2B	56.7M	2026-03